After seeing such a move in DNDN based on Phase 3 results, it makes me more encouraged to get aggresive with a stock like SVNT. DNDN has just gone from 4 to 20 in just a week. Its amazing that alot of small cap biotechs have lagged the recent market rally. They biotechs didn't outperform in the market crash and now they aren't participating in the rally even with big cap Pharma companies loaded with cash and looking for deals. Maybe Mr. Market knows that they aren't looking in the small cap area. Both RIGL and SVNT haven't recently pulled up on partnerships or even buyouts in theory b/c the prices weren't good enough. Seems to be a huge diconnect in the market leaving me to thing a DNDN type surge could take place on SVNT and even RIGL.